Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF ISIN · CA74319B5027 US Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2021-05-21 Declaration of Voting R…
Country US United States of America
Listing US PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company that develops and markets incision-free therapies for ablative interventions. The company's primary platform, TULSA-PRO®, combines real-time Magnetic Resonance (MR) imaging with robotically-driven, transurethral thermal ultrasound and closed-loop temperature feedback. This system is designed for the precise and customizable ablation of prostate tissue from the inside-out. It is used to treat various conditions, including localized prostate cancer and benign prostatic hyperplasia (BPH). The technology enables physicians to create customized treatment plans and monitor tissue temperature in real-time, aiming to maximize efficacy while preserving patient quality of life.

Recent filings

Filing Released Lang Actions
FORM 6-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., under the SEC rules. It includes an exhibit titled 'Report of Voting Results'. The document length is 1835 characters, which is relatively short and mainly serves as a cover report referencing the attached voting results. There is no substantive financial data or detailed report content within the text itself. According to the 'Menu vs Meal' rule, this is an announcement or filing referencing voting results rather than the full detailed report. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-05-21 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1452 characters), and it primarily serves as a regulatory filing to report information to the SEC. There is no indication that this is a full annual report, earnings release, or other detailed financial report. According to the rules, Form 6-K filings are typically classified under Regulatory Filings (RNS) as they are miscellaneous filings that do not fit other specific categories and often serve as periodic updates or disclosures by foreign issuers.
2021-05-19 English
FORM 6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It includes exhibits such as unaudited interim condensed consolidated financial statements and Management's Discussion and Analysis (MD&A). The presence of interim financial statements and MD&A indicates this is an interim or quarterly report filing. The document length is 1887 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2021-05-12 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1450 characters), and it primarily serves as a regulatory filing to report information to the SEC. According to the rules, Form 6-K filings are considered Regulatory Filings (RNS) as they are periodic reports for foreign issuers that do not constitute full annual or interim reports. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-05-06 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer submitted to the SEC under the Securities Exchange Act of 1934. It includes an exhibit index referencing a Notice of Annual Meeting and Management Information Circular and a Form of Proxy. The document length is 1911 characters, which is relatively short and mainly serves as an announcement or filing rather than a full report. It does not contain detailed financial statements or substantive financial data. The presence of a proxy and notice of annual meeting suggests it relates to shareholder meeting materials. Given the short length and nature of the content, this is not the full Annual Report or Management Report but rather a regulatory filing announcing or providing meeting materials. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other categories.
2021-04-22 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It is a report of a foreign private issuer under the Securities Exchange Act of 1934, specifically for April 2021. The document is short (1458 characters) and primarily serves as a cover page referencing an attached press release (Exhibit 99.1). There is no substantive financial data or detailed report content within this text. According to the rules, such short filings that announce or attach other documents without containing the full report themselves should be classified as Regulatory Filings (RNS).
2021-04-21 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.